Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui Enrich Biotechnology is a specialized pharmaceutical chemicals company focused on the research, development, and large-scale manufacturing of high-end pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs). Headquartered in Hefei, China, the company is a leading provider of nucleoside and nucleotide analogs, which are essential components for antiviral and oncology therapeutics. Enrich Biotechnology gained significant industry recognition for its role in the global supply chain for critical antiviral drugs, including intermediates for Remdesivir and Molnupiravir. The company operates advanced R&D and production facilities that adhere to international quality standards, serving as a strategic partner for global pharmaceutical innovators.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anhui Enrich Biotechnology.